Fulton Bank, N.A. Pfizer Inc Transaction History

Fulton Bank, N.A.

$1.13 Billion
Q1 2025

A detailed history of Fulton Bank, N.A. transactions in Pfizer Inc stock. As of the latest transaction made, Fulton Bank, N.A. holds 79,908 shares of PFE stock, worth $1.77 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

79,908

Previous 97,044 17.66%

Holding current value

$1.77 Million

Previous $2.57 Million 21.37%

% of portfolio

0.18%

Previous 0.21%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 09, 2025	SELL	$25.01 - $27.13 $428,571 - $464,899	-17,136 Reduced 17.66%	79,908 $2.02 Million
Q4 2024 Jan 08, 2025	SELL	$24.8 - $30.19 $700,302 - $852,505	-28,238 Reduced 22.54%	97,044 $2.57 Million
Q3 2024 Oct 07, 2024	BUY	$27.7 - $31.39 $254,507 - $288,411	9,188 Added 7.91%	125,282 $3.63 Million
Q2 2024 Jul 09, 2024	BUY	$25.26 - $29.6 $148,402 - $173,900	5,875 Added 5.33%	116,094 $3.25 Million
Q1 2024 Apr 10, 2024	SELL	$25.89 - $29.73 $1.63 Million - $1.87 Million	-63,020 Reduced 36.38%	110,219 $3.06 Million
Q4 2023 Jan 04, 2024	SELL	$26.13 - $33.94 $78,390 - $101,820	-3,000 Reduced 1.7%	173,239 $4.99 Million
Q3 2023 Oct 04, 2023	BUY	$32.09 - $37.51 $256,431 - $299,742	7,991 Added 4.75%	176,239 $5.85 Million
Q2 2023 Jul 06, 2023	BUY	$36.12 - $41.79 $259,413 - $300,135	7,182 Added 4.46%	168,248 $6.17 Million
Q1 2023 Apr 06, 2023	BUY	$39.39 - $51.28 $823,014 - $1.07 Million	20,894 Added 14.91%	161,066 $6.57 Million
Q4 2022 Jan 05, 2023	BUY	$41.75 - $54.5 $173,304 - $226,229	4,151 Added 3.05%	140,172 $7.18 Million
Q3 2022 Oct 04, 2022	BUY	$43.76 - $53.42 $153,335 - $187,183	3,504 Added 2.64%	136,021 $5.95 Million
Q2 2022 Jul 07, 2022	SELL	$46.53 - $55.17 $371,309 - $440,256	-7,980 Reduced 5.68%	132,517 $6.95 Million
Q1 2022 Apr 05, 2022	SELL	$45.75 - $56.69 $193,568 - $239,855	-4,231 Reduced 2.92%	140,497 $7.27 Million
Q4 2021 Jan 05, 2022	SELL	$41.32 - $61.25 $967,177 - $1.43 Million	-23,407 Reduced 13.92%	144,728 $8.55 Million
Q3 2021 Oct 05, 2021	SELL	$39.25 - $50.42 $490,860 - $630,552	-12,506 Reduced 6.92%	168,135 $7.23 Million
Q2 2021 Jul 06, 2021	BUY	$35.91 - $40.68 $291,553 - $330,280	8,119 Added 4.71%	180,641 $7.07 Million
Q1 2021 Apr 05, 2021	BUY	$33.49 - $37.77 $39,853 - $44,946	1,190 Added 0.69%	172,522 $6.25 Million
Q4 2020 Jan 07, 2021	SELL	$33.47 - $42.56 $115,404 - $146,746	-3,448 Reduced 1.97%	171,332 $6.31 Million
Q3 2020 Oct 06, 2020	BUY	$31.75 - $37.25 $323,818 - $379,912	10,199 Added 6.2%	174,780 $6.41 Million
Q2 2020 Jul 06, 2020	SELL	$30.12 - $36.54 $103,853 - $125,989	-3,448 Reduced 2.05%	164,581 $5.38 Million
Q1 2020 Apr 03, 2020	BUY	$27.03 - $38.62 $61,439 - $87,783	2,273 Added 1.37%	168,029 $5.48 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $1.33 Million - $1.51 Million	40,459 Added 32.29%	165,756 $6.49 Million
Q3 2019 Oct 03, 2019	BUY	$32.49 - $42.13 $1.66 Million - $2.15 Million	50,978 Added 68.59%	125,297 $4.5 Million
Q2 2019 Jul 03, 2019	BUY	$36.98 - $41.52 $94,779 - $106,415	2,563 Added 3.57%	74,319 $3.22 Million
Q1 2019 Apr 03, 2019	SELL	$37.5 - $41.2 $181,687 - $199,614	-4,845 Reduced 6.32%	71,756 $3.05 Million
Q4 2018 Jan 03, 2019	SELL	$38.47 - $43.86 $631,369 - $719,830	-16,412 Reduced 17.64%	76,601 $3.34 Million
Q3 2018 Oct 03, 2018	BUY	$34.47 - $41.81 $428,772 - $520,074	12,439 Added 15.44%	93,013 $4.1 Million
Q2 2018 Jul 10, 2018	BUY	$32.98 - $35.16 $724,141 - $772,008	21,957 Added 37.46%	80,574 $2.92 Million
Q1 2018 May 02, 2018	BUY	$31.91 - $37.02 $82,902 - $96,177	2,598 Added 4.64%	58,617 $2.08 Million
Q4 2017 Jan 04, 2018	BUY	$33.26 - $35.29 $22,982 - $24,385	691 Added 1.25%	56,019 $2.03 Million
Q3 2017 Oct 04, 2017	BUY	$31.0 - $34.15 $1.72 Million - $1.89 Million	55,328	55,328 $1.98 Million

Others Institutions Holding PFE

# of Institutions

3,376

Shares Held

3.56B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $124B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account